Filing Details

Accession Number:
0001209191-16-105840
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-03 21:26:30
Reporting Period:
2016-03-02
Filing Date:
2016-03-03
Accepted Time:
2016-03-03 21:26:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591313 R John Desjarlais C/O Xencor, Inc.
111 West Lemon Avenue
Monrovia CA 91016
Sr. V.p., Research & Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-02 28,653 $0.59 57,709 No 4 M Direct
Common Stock Disposition 2016-03-02 11,625 $12.01 46,084 No 4 S Direct
Common Stock Acquisiton 2016-03-03 6,888 $0.59 52,972 No 4 M Direct
Common Stock Disposition 2016-03-03 2,635 $12.00 50,337 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-03-02 28,653 $0.00 28,653 $0.59
Common Stock Stock Option (right to buy) Disposition 2016-03-03 6,888 $0.00 6,888 $0.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,888 2016-12-31 No 4 M Direct
0 2016-12-31 No 4 M Direct
Footnotes
  1. Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted December 14, 2015.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. The stock option is fully vested and exercisable.